Neuromolecular Medicine
 | |
Abbreviated title (ISO 4) | Neuromol. Med. |
|---|---|
| Discipline | Neurology, molecular medicine |
| Language | English |
| Edited by | Mark P. Mattson |
| Publication details | |
| Publisher | |
Publication history | 2002-present |
| Frequency | Quarterly |
| Indexing | |
| ISSN |
1535-1084 (print) 1559-1174 (web) |
| LCCN | 2001213164 |
| CODEN | NMEEAN |
| OCLC no. | 605176440 |
| Links | |
NeuroMolecular Medicine is a quarterly peer-reviewed medical journal covering research on the molecular and biochemical basis of neurological disorders. It is published by Springer Science+Business Media and the editor-in-chief is Mark P. Mattson (National Institute on Aging).
Abstracting and indexing
The journal is abstracted and indexed in:
According to the Journal Citation Reports, the journal has a 2012 impact factor of 4.492.[1]
References
- ↑ "NeuroMolecular Medicine". 2012 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2013.
External links
This article is issued from Wikipedia - version of the Tuesday, November 18, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.